Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Giroux RichardCFO & COO |  MGTXMeiraGTx Holdings plcOpen-market sale · 10b5-1 plan | SELL | $572K 56.0K sh | Apr 21, 2026 |
| 20 | Atkinson NajumaDirector |  MQMarqeta, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 9,259 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 20 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $18.73M 107.6K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 19 | Liu DongfangCHIEF MEDICAL OFFICER |  NUVBNuvation Bio Inc.Open-market sale · 10b5-1 plan | SELL | $251K 50.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 19 | Sharma PankajChief Business Officer |  RELYRemitly Global, Inc.Open-market sale · 10b5-1 plan | SELL | $200K 10.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 19 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $150K 750 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 19 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $277K 19.1K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 19 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $150K 750 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 19 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $278K 19.1K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $6,336 15 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Eltoukhy AdamSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $3,119 100 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 46 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $6,693 16 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 84 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 18 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 50 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $3.00M 17.9K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $6.71M 39.3K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $5.53M 32.2K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.14M 6,526 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $4.91M 29.1K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $3.33M 19.3K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $7.85M 45.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $6.01M 35.4K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 16 | Valente ManuelaChief People Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $1,977 380 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 16 | Bradbury Robyn LChief Financial Officer |  CNMCore & Main, Inc.Open-market sale · 10b5-1 plan | SELL | $177K 3,353 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 14 | Gupta VikramSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $125K 1,548 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Pearson MarkDirector, President and CEO |  EQHEquitable Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $1.65M 39.7K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $644K 3,662 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,554 684 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,165 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,955 760 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $23K 4,486 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,162 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 12 | Bradbury Robyn LChief Financial Officer | CNMCore & Main, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 1,647 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 10 | Sevalia Piyush BSee Remarks |  SITMSITIME CorpOpen-market sale · 10b5-1 plan | SELL | $1.17M 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Wasechek WayneEVP and CFO |  RYNRAYONIER INCOpen-market sale · 10b5-1 plan | SELL | $62K 2,920 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |